TabletAnti Diabetic

Glimepiride + Voglibose

Glimepiride + Voglibose · Sulfonylurea and alpha-glucosidase inhibitor combination

TabletAnti Diabetic

Glimepiride + VogliboseProspero Healthcare

Glimepiride + Voglibose is a sulfonylurea and alpha-glucosidase inhibitor combination supplied as tablets. It is used in standard clinical practice for type 2 diabetes mellitus, as described in general pharmacological references.

Uses

Type 2 diabetes mellitus

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Glimepiride + Voglibose
Available strengthsIndicative: 1 mg + 0.2 mg · 2 mg + 0.2 mg
Dosage form: Tablet
Therapeutic category: Anti Diabetic
Therapeutic class: Sulfonylurea and alpha-glucosidase inhibitor combination
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category